跳至主要内容
临床试验/NCT02087202
NCT02087202Unknown不适用

Hyperalgesia and NMDA Receptor Antagonist

Seoul National University Bundang Hospital0 个研究点目标入组 90 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
90
主要终点
pain

研究概览

简要总结

NMDA receptor is administered and postoperative remote hyperalgesia is investigated.

详细描述

NMDA receptor is adminstered and postoperative tertiary hyperalgesia is investigated.

QST and pain measures for remote hyperalgesia are compared between control and magnesium or ketamine group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • contraindication to the study drugs

研究组 & 干预措施

magnesium

Experimental

magnesium is added perioperatively to those patients undergoing staged total knee arthroplasty and other surgeries.

干预措施: Magnesium Sulfate (Drug)

ketamine

Experimental

ketamine is administered to those patients undergoing stated TKA and other operations.

干预措施: ketamine (Drug)

结局指标

主要结局

pain

时间窗: until 1 month from the end of the operation

pain (QST and pain measures )until 1 month from the end of the operation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kim Mihyun

clinical professor

Seoul St. Mary's Hospital

相似试验

Hyperalgesia and NMDA Receptor Antagonist | 临床试验